(1997). Farese RVJ: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CC chemokine receptor 2 knockout mice.
(1997). Hughes BG: Echinaceainduced cytokine production by human macrophages.
(1997). Human Chemokines: an update. Annu Rev Immunol
(1992). Identification of proliferating dendritic cell precursors in mouse blood.
(2000). IF: A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses.
(1998). Immunologic in vivo and in vitro examinations of Echinacea extracts. Arzneim Forsch
(2005). Immunotherapy via dendritic cells. Adv Exp Med Biol
(1992). Knick E: Enhancement of resistance in common cold by Echinacea purpurea. Z Phytother
(1997). Langerhans’ cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology
(2005). LJ: Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics
(1991). LohmannMatthes ML: Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system.
(1998). Molecular basis of T cell inactivation by CTLA-4. Science
(2008). NS: Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells.
(2004). Overcoming Self: A company tries to turn the immune system against cancer. Scientific American
(2002). Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol
(2002). PL: Cancer vaccines and immunotherapy. Br Med Bull
(2000). Proteomics to study genes and genomes. Nature
(2001). Renno T: Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTL induction.
(2003). RR: Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Current Biology
(2002). Schmidt-Wolf IG: Generation of dendritic cell-based vaccines for cancer therapy.
(2005). SF: A network-based analysis of systemic inflammation in humans. Nature
(2002). Shyur LF: Profiling and characterization of antioxidant activities in Anoectochilus formosanus Hayata. J Agric Food Chem
(2006). SL: Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther
(1997). Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.
The risk-benefit profile of commonly used herbal therapies.
(2002). TK: Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol
(1993). Udey MC: Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature
(1998). Udey MC: Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo.
(1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Nat Med
(2006). Yang NS: Modulatory effects of Echinacea purpurea extracts on human dendritic cells: A cell- and gene-based study. Genomics